Caladrius Biosciences, Inc.
USD0.43
-0.09 (-16.75%)
CEO
David Mazzo
IPO Date
1995-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.65
Prev. Close
$0.51
Day Low
$0.38
Day High
$0.65
Market Cap
$0.00B
Volume
26.95M
| 69,742 |
| $0.50 |
| 18 Jan 2022 | Mazzo David J | director, officer: Chief Executive Officer | F-InKind | Disposed | 6,471 | $0.81 |
| 18 Jan 2022 | Mazzo David J | director, officer: Chief Executive Officer | F-InKind | Disposed | 6,611 | $0.82 |
| 12 Jan 2022 | MYERS STEVEN S | director | A-Award | Acquired | 65,430 | $0.00 |
| 12 Jan 2022 | KLOSK STEVEN M | director | A-Award | Acquired | 65,430 | $0.00 |
| 12 Jan 2022 | Davidson Michael H. | director | A-Award | Acquired | 65,430 | $0.00 |
| 12 Jan 2022 | TRABER PETER G | director | A-Award | Acquired | 65,430 | $0.00 |
| 12 Jan 2022 | BROWN GREGORY B | director | A-Award | Acquired | 65,430 | $0.00 |
| 12 Jan 2022 | Whitaker Anne Clem | director | A-Award | Acquired | 65,430 | $0.00 |